Mark Sleeman

Person

Melbourne, AU

People

Patents Grantslast 30 patents

Information Patent Grant
Human antibodies to the human glucagon receptor (HGCGR) and methods...
- Patent number 12,269,889
- Issue date Apr 8, 2025
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PCSK9 antibodies
- Patent number 12,269,897
- Issue date Apr 8, 2025
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding proteins to the human thrombin receptor, PAR4
- Patent number 11,780,915
- Issue date Oct 10, 2023
- Monash University
- Justin Hamilton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to the human glucagon receptor and methods of use...
- Patent number 11,498,970
- Issue date Nov 15, 2022
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-PCSK9 antibodies
- Patent number 10,941,210
- Issue date Mar 9, 2021
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules encoding antibodies to the human glucagon re...
- Patent number 10,640,566
- Issue date May 5, 2020
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ANGPTL3 antibodies and uses thereof
- Patent number 10,358,487
- Issue date Jul 23, 2019
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human antibodies to the glucagon receptor and methods of use thereo...
- Patent number 10,233,250
- Issue date Mar 19, 2019
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-PCSK9 antibodies
- Patent number 10,023,654
- Issue date Jul 17, 2018
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ANGPTL3 antibodies and uses thereof
- Patent number 9,951,127
- Issue date Apr 24, 2018
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating hypercholesterolemia and reducing LDL-C using...
- Patent number 9,724,411
- Issue date Aug 8, 2017
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to the glucagon receptor and methods of use thereof
- Patent number 9,587,029
- Issue date Mar 7, 2017
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic uses of anti-PCSK9 antibodies
- Patent number 9,550,837
- Issue date Jan 24, 2017
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding human glucagon receptor antibodies
- Patent number 9,127,068
- Issue date Sep 8, 2015
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ANGPTL3 antibodies and uses thereof
- Patent number 9,018,356
- Issue date Apr 28, 2015
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to the human glucagon receptor and methods of use...
- Patent number 8,545,847
- Issue date Oct 1, 2013
- REGENERON PHARMACEUTICALS, INC.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-PCSK9 ANTIBODIES
- Publication number 20250154286
- Publication date May 15, 2025
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4
- Publication number 20240117031
- Publication date Apr 11, 2024
- MONASH UNIVERSITY
- Justin HAMILTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20230192874
- Publication date Jun 22, 2023
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
- Publication number 20220403016
- Publication date Dec 22, 2022
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
- Publication number 20220153825
- Publication date May 19, 2022
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PCSK9 ANTIBODIES
- Publication number 20210253735
- Publication date Aug 19, 2021
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- G01 - MEASURING TESTING
Information Patent Application
BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4
- Publication number 20210179707
- Publication date Jun 17, 2021
- MONASH UNIVERSITY
- Justin HAMILTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20200247896
- Publication date Aug 6, 2020
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
- Publication number 20190315851
- Publication date Oct 17, 2019
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20190144552
- Publication date May 16, 2019
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PCSK9 ANTIBODIES
- Publication number 20190135941
- Publication date May 9, 2019
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
- Publication number 20190092845
- Publication date Mar 28, 2019
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using...
- Publication number 20170296657
- Publication date Oct 19, 2017
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20170129960
- Publication date May 11, 2017
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
- Publication number 20170096496
- Publication date Apr 6, 2017
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20150337045
- Publication date Nov 26, 2015
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
- Publication number 20150284474
- Publication date Oct 8, 2015
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-ANGPTL3 Antibodies and Uses Thereof
- Publication number 20150197564
- Publication date Jul 16, 2015
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using...
- Publication number 20140099312
- Publication date Apr 10, 2014
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
- Publication number 20130344538
- Publication date Dec 26, 2013
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-ANGPTL3 Antibodies and Uses Thereof
- Publication number 20130171149
- Publication date Jul 4, 2013
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
- Publication number 20130085266
- Publication date Apr 4, 2013
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING HYPERCHOLESTEROLEMIA USING ANTIBODIES TO PCSK9
- Publication number 20130064834
- Publication date Mar 14, 2013
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies to the Glucagon Receptor
- Publication number 20120128679
- Publication date May 24, 2012
- Regeneron Pharmaceuticals, Inc.
- Haruka Okamoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Sleeman

Person

Patents Grantslast 30 patents

Human antibodies to the human glucagon receptor (HGCGR) and methods...

Anti-PCSK9 antibodies

Binding proteins to the human thrombin receptor, PAR4

Human antibodies to the human glucagon receptor and methods of use...

Anti-PCSK9 antibodies

Nucleic acid molecules encoding antibodies to the human glucagon re...

Anti-ANGPTL3 antibodies and uses thereof

Human antibodies to the glucagon receptor and methods of use thereo...

Anti-PCSK9 antibodies

Anti-ANGPTL3 antibodies and uses thereof

Methods for treating hypercholesterolemia and reducing LDL-C using...

Human antibodies to the glucagon receptor and methods of use thereof

Therapeutic uses of anti-PCSK9 antibodies

Nucleic acids encoding human glucagon receptor antibodies

Anti-ANGPTL3 antibodies and uses thereof

Human antibodies to the human glucagon receptor and methods of use...

Patents Applicationslast 30 patents

ANTI-PCSK9 ANTIBODIES

BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

ANTI-PCSK9 ANTIBODIES

BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-PCSK9 ANTIBODIES

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

Methods for Treating Hypercholesterolemia and Reducing LDL-C Using...

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS

Anti-ANGPTL3 Antibodies and Uses Thereof

Methods for Treating Hypercholesterolemia and Reducing LDL-C Using...

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

Anti-ANGPTL3 Antibodies and Uses Thereof

ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS

METHODS FOR TREATING HYPERCHOLESTEROLEMIA USING ANTIBODIES TO PCSK9

Human Antibodies to the Glucagon Receptor